Novartis AG (NOVN.SW) Stock Overview
Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.
Novartis AG (NOVN.SW)
Key Financials
Key Financials
Market Cap
238.7B
P/E Ratio
23.46
EPS (TTM)
$6.87
ROE
0.30%
NOVN.SW Stock Analysis & Investment Overview (SIX)
Our AI-powered analysis of Novartis AG (SIX: NOVN.SW) gives investors deep insight into how the stock performs on the SIX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Novartis AG's SIX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of NOVN.SW on the SIX shows an RSI of 52.02, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $131.27 for the SIX listing.
Key metrics behind Novartis AG's SIX-traded stock include a P/E ratio of 23.46 and a market capitalization of 238.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of NOVN.SW on the SIX.